Distributional Cost-Effectiveness Analysis (DCEA)
Distributional Cost-Effectiveness Analysis (DCEA) is a method that helps decision-makers consider both the overall health benefits and how fairly those benefits are shared across different groups in society when evaluating health interventions. It extends traditional cost-effectiveness analysis by also looking at whether an intervention reduces or increases health inequalities.
At a glance
Use when
Evaluating health interventions where equity impacts are a policy concern; when decision-makers need to balance efficiency and fairness; when health inequality is a stated objective of the health system
Avoid when
Equity considerations are not a policy priority; insufficient data to stratify health outcomes by relevant equity dimensions; when simplicity and speed are prioritized over detailed distributional insights
Inputs
Health outcome data stratified by social characteristics (e.g., socioeconomic status), cost data, social value parameters (e.g., inequality aversion weights)
Outputs
Distributional results including inequality-adjusted incremental cost-effectiveness ratios, health inequality impact measures, and sensitivity analysis results
How it works
DCEA involves two main stages: 1) modeling the social distribution of health outcomes across different population groups under alternative interventions, and 2) evaluating these distributions based on both total population health improvement and reduction of unfair health inequalities. The method incorporates social value judgments, such as inequality aversion parameters, and uses sensitivity analyses to test the robustness of results to different assumptions about inequality weights and distributional impacts. An illustrative application compares implementation strategies for the NHS Bowel Cancer Screening Programme.
- HTA domains
- Costs & Economic Evaluation, Patient and Social Aspects, Aspects Beyond HTA
- Assumptions
- Health inequality can be measured and valued using social weights; social value judgments (e.g., degree of inequality aversion) can be defined; health outcomes can be reliably stratified by relevant equity-relevant characteristics
- Strengths
- Explicitly incorporates equity concerns into economic evaluation; allows transparency in value judgments; supports policy decisions that aim to reduce health inequalities; compatible with standard cost-effectiveness analysis frameworks
- Limitations
- Requires detailed, stratified health data which may not be available; results depend on chosen inequality weights which can be subjective; increased complexity compared to standard CEA; limited guidance on selecting default social value parameters
- Also known as
- DCEA
Questions this answers
- › How does an intervention affect overall population health?
- › How are health benefits distributed across different social groups?
- › Does the intervention reduce or increase health inequality?
- › What is the trade-off between improving total health and reducing inequality?
- › How sensitive are results to assumptions about inequality aversion?
- › Which intervention provides the best balance of efficiency and equity?
References & sources
Similar by meaning
- Aggregate Distributional Cost-Effectiveness Analysis (ADCEA)
- Extended Cost-Effectiveness Analysis (ECEA)
- Generalized Cost-Effectiveness Analysis (GCEA / WHO-CHOICE)
- Discrete Choice Experiments in Health Economics: Past, Present and Future
- Toolbox for decrementally cost-effective interventions (d-CEIs) in HTA
Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.